Click for best price
Postpemic Era Lower GI Series Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Lower GI Series Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Lower GI Series industry at home and abroad, estimate the overall market scale of the Lower GI Series industry and the market share of major countries, Lower GI Series industry, and study and judge the downstream market demand of Lower GI Series through systematic research, Analyze the competition pattern of Lower GI Series, so as to help solve the pain points of various stakeholders in Lower GI Series industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Lower GI Series Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Lower GI Series Market?
Eisai
Cadila Pharmaceuticals
Purdue Pharma
Peacehealth
Novadaq
Astrazeneca
Ironwood Pharmaceuticals
Major Type of Lower GI Series Covered in XYZResearch report:
Double-Contrast
Single-Contrast
Application Segments Covered in XYZResearch Market
Hospital
Clinic
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Lower GI Series Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
87 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Lower GI Series Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Lower GI Series Market by Value
2.2.1 Global Lower GI Series Revenue by Type
2.2.2 Global Lower GI Series Market by Value
2.3 Global Lower GI Series Market by Sales
2.3.1 Global Lower GI Series Sales by Type
2.3.2 Global Lower GI Series Market by Sales
3. The Major Driver of Lower GI Series Industry
3.1 Historical & Forecast Global Lower GI Series Sales and Revenue (2018-2028)
3.2 Largest Application for Lower GI Series (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Lower GI Series Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Lower GI Series Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Lower GI Series Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Lower GI Series Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Lower GI Series Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Lower GI Series Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Lower GI Series Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Lower GI Series Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Lower GI Series Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Lower GI Series Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Lower GI Series Average Price Trend
13.1 Market Price for Each Type of Lower GI Series in US (2018-2022)
13.2 Market Price for Each Type of Lower GI Series in Europe (2018-2022)
13.3 Market Price for Each Type of Lower GI Series in China (2018-2022)
13.4 Market Price for Each Type of Lower GI Series in Japan (2018-2022)
13.5 Market Price for Each Type of Lower GI Series in India (2018-2022)
13.6 Market Price for Each Type of Lower GI Series in Korea (2018-2022)
13.7 Market Price for Each Type of Lower GI Series in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Lower GI Series in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Lower GI Series Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Lower GI Series
15. Lower GI Series Competitive Landscape
15.1 Eisai
15.1.1 Eisai Company Profiles
15.1.2 Eisai Product Introduction
15.1.3 Eisai Lower GI Series Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Cadila Pharmaceuticals
15.2.1 Cadila Pharmaceuticals Company Profiles
15.2.2 Cadila Pharmaceuticals Product Introduction
15.2.3 Cadila Pharmaceuticals Lower GI Series Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Purdue Pharma
15.3.1 Purdue Pharma Company Profiles
15.3.2 Purdue Pharma Product Introduction
15.3.3 Purdue Pharma Lower GI Series Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Peacehealth
15.4.1 Peacehealth Company Profiles
15.4.2 Peacehealth Product Introduction
15.4.3 Peacehealth Lower GI Series Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Novadaq
15.5.1 Novadaq Company Profiles
15.5.2 Novadaq Product Introduction
15.5.3 Novadaq Lower GI Series Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Astrazeneca
15.6.1 Astrazeneca Company Profiles
15.6.2 Astrazeneca Product Introduction
15.6.3 Astrazeneca Lower GI Series Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Ironwood Pharmaceuticals
15.7.1 Ironwood Pharmaceuticals Company Profiles
15.7.2 Ironwood Pharmaceuticals Product Introduction
15.7.3 Ironwood Pharmaceuticals Lower GI Series Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Lower GI Series Industry (Volume)
Figure 2. Lower GI Series Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Lower GI Series Revenue in 2022
Figure 5. US Lower GI Series Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Lower GI Series Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Lower GI Series Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Lower GI Series Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Lower GI Series Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Lower GI Series Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Lower GI Series Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Lower GI Series Revenue, by Type (Million USD) (2018-2028)
Table 4. Lower GI Series Sales, by Type (K Unit) (2018-2028)
Table 5. Lower GI Series Sales (K Unit) by Application (2018-2028)
Table 6. Lower GI Series Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Lower GI Series Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Lower GI Series Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Lower GI Series Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Lower GI Series Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Lower GI Series Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Lower GI Series Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Lower GI Series Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Lower GI Series Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Lower GI Series in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Lower GI Series in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Lower GI Series in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Lower GI Series in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Lower GI Series in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Lower GI Series in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Lower GI Series in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Eisai Profiles
Table 61. Eisai Lower GI Series Product Introduction
Table 62. Eisai Lower GI Series Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Eisai Strategic initiatives
Table 64. Cadila Pharmaceuticals Profiles
Table 65. Cadila Pharmaceuticals Lower GI Series Product Introduction
Table 66. Cadila Pharmaceuticals Lower GI Series Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Cadila Pharmaceuticals Strategic initiatives
Table 68. Purdue Pharma Profiles
Table 69. Purdue Pharma Lower GI Series Product Introduction
Table 70. Purdue Pharma Lower GI Series Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Purdue Pharma Strategic initiatives
Table 72. Peacehealth Profiles
Table 73. Peacehealth Lower GI Series Product Introduction
Table 74. Peacehealth Lower GI Series Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Peacehealth Strategic initiatives
Table 76. Novadaq Profiles
Table 77. Novadaq Lower GI Series Product Introduction
Table 78. Novadaq Lower GI Series Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Novadaq Strategic initiatives
Table 80. Astrazeneca Profiles
Table 81. Astrazeneca Lower GI Series Product Introduction
Table 82. Astrazeneca Lower GI Series Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Astrazeneca Strategic initiatives
Table 84. Ironwood Pharmaceuticals Profiles
Table 85. Ironwood Pharmaceuticals Lower GI Series Product Introduction
Table 86. Ironwood Pharmaceuticals Lower GI Series Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Ironwood Pharmaceuticals Strategic initiatives
